\u003cp\u003eKnown as the âblue bookâ, the \u003cem\u003eGynecologic Oncology Handbook: An Evidence-Based Clinical Guide\u003c/em\u003e is an invaluable resource for fellows, residents, and clinicians in the diagnosis and management of gynecologic cancers. Retaining the format and features that have made it a leading practical reference, this new edition has been thoroughly updated and reflects the latest advances in surgical techniques, chemotherapy protocols, breakthroughs in immunotherapies and targeted therapies, and much more.\u003c/p\u003e\u003cp\u003eThe handbook covers the full scope of disease management in a concise and accessible format. Its compact size allows it to be easily taken with the busy practitioner on the ward or in the clinic. Clear illustrations that reinforce key concepts and essential algorithms for diagnostic techniques help clinicians to a quick and accurate diagnosis. Evidence-based practices for managing gynecologic cancers are emphasized throughout the handbook including for surgical care, and for all adjuvant therapies including chemotherapy, biologics, targeted therapies, immunotherapies, and combination radiation therapy. Detailed sections on survivorship care, palliative care, and management of reproductive function and other comorbid medical conditions round out the bookâs comprehensive scope.\u003c/p\u003e \u003cp\u003eIts extensive coverage of current breakthroughs in treatment, references to critical clinical studies, and breakdown of directed gynecologic cancer workups and treatments make the \u003cem\u003eGynecologic Oncology Handbook\u003c/em\u003e, 3rd Edition a go-to resource within the fieldâincluding in preparation for the gynecologic oncology subspecialty certification oral board exam.\u003c/p\u003e \u003cp\u003e\u003cstrong\u003eKey Features:\u003c/strong\u003e\u003c/p\u003e \u003cul\u003e\u003cli\u003eCovers all fundamentals of gynecologic oncology including workup, AJCC and FIGO staging, surgical management, chemotherapy, targeted therapy, immunotherapy, and radiation therapy treatment, comorbidity diagnosis and management, and background study data\u003c/li\u003e \u003cli\u003eContains insight into recently approved immunotherapies for recurrent advanced and metastatic cervical and uterine disease\u003c/li\u003e\u003cli\u003eProvides Gynecologic Oncology Referral Parameters, Performance Status Scales, Adverse Event Grading, RECIST evaluation criteria, chemotherapy protocols, statistics, and other useful formulas\u003c/li\u003e\u003cli\u003eIncludes clinical study references, medical comorbidity algorithms, directed workups, and treatment guidelines\u003c/li\u003e\u003c/ul\u003e
nl
en